FDA: Pancreatic enzyme medically necessary

Pancreatic enzyme replacement products have been around for a long time, but have largely existed as nutritional supplements. Yesterday, an FDA official said the products are medically necessary, which might mean an approval is in store for Solvay's Creon. Creon and similar products aim to help patients with chronic pancreatitis, cystic fibrosis and other conditions that require replacement of pancreatic enzymes essential for digestion. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.